NeuroSense Therapeutics (NRSN) Interest & Investment Income (2021 - 2023)
NeuroSense Therapeutics' Interest & Investment Income was $338,000 in Q4 2023, up 64.1% from $206,000 a year earlier but down 90.8% from the prior quarter.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Interest & Investment Income (2021 - 2023) Analysis & Trends
For FY2023, Interest & Investment Income at NeuroSense Therapeutics came in at $4.23 million, up 236.6% from FY2022.
- Interest & Investment Income shows a four-year compound annual growth rate of 291.6% (FY2019 to FY2023).
- In earlier years, Interest & Investment Income was $1.26 million in FY2022 (-54.0%), $2.73 million in FY2021, $61,000 in FY2020 (+238.9%) and $18,000 in FY2019.
- Quarterly Interest & Investment Income has moved between -$8,000 (Q3 2021) and $3.69 million (Q3 2023) over five years.
- Compared with a year earlier, Interest & Investment Income was higher in 1 of the last four quarters, with an average decline of 30.4%.
- Per Business Quant data, NRSN's Interest & Investment Income in the three quarters before Q4 2023 was $3.69 million (Q3 2023), $138,000 (Q2 2023) and $62,000 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | NeuroSense Therapeutics | 4.00 Mn | -436,466.80 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 338,000.00 |
| Sep 30, 2023 | 3.69 Mn |
| Jun 30, 2023 | 138,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | 206,000.00 |
| Sep 30, 2022 | 335,000.00 |
| Jun 30, 2022 | 144,000.00 |
| Mar 31, 2022 | 572,000.00 |
| Dec 31, 2021 | 2.73 Mn |
API Access
NeuroSense Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();